Actionable news
All posts from Actionable news
Actionable news in FPRX: Five Prime Therapeutics, Inc.,

Bristol-Myers, Five Prime enter licensing deal of up to $1.74 billion

Bristol-Myers Squibb Co said on Thursday it agreed to exclusively license and collaborate with Five Prime Therapeutics Inc to develop and commercialize Five Prime's antibody program in the treatment of cancer.

Five Prime will receive $350 million...